Division of Alcohol and Drug Abuse, McLean Hospital, Belmont MA 02478, USA.
J Subst Abuse Treat. 2013 Jul;45(1):38-43. doi: 10.1016/j.jsat.2012.12.007. Epub 2013 Jan 11.
Although gender differences in substance use disorders have been identified, few studies have examined gender differences in prescription drug dependence. The aim of this study was to examine gender differences in clinical characteristics and treatment outcomes in a large clinical trial for prescription opioid dependence. Despite no pre-treatment differences in opioid dependence severity, women reported significantly greater functional impairment, greater psychiatric severity, and higher likelihood of using opioids to cope with negative affect and pain than men. Women were also more likely than men to have first obtained opioids via a legitimate prescription and to use opioids via the intended route of administration. Men reported significantly more alcohol problems than women. There were no significant gender differences in medication dose, treatment retention, or opioid outcomes. Thus, despite the presence of pre-treatment gender differences in this population, once the study treatment was initiated, women and men exhibited similar opioid use outcomes.
尽管已经确定了物质使用障碍方面的性别差异,但很少有研究检查处方药物依赖方面的性别差异。本研究的目的是在一项大型临床研究中检查处方阿片类药物依赖患者的临床特征和治疗结果的性别差异。尽管阿片类药物依赖严重程度在治疗前没有差异,但女性报告的功能障碍、精神疾病严重程度以及使用阿片类药物来应对负面情绪和疼痛的可能性明显大于男性。女性也比男性更有可能通过合法处方获得阿片类药物,并通过预期的给药途径使用阿片类药物。男性报告的酒精问题明显多于女性。在药物剂量、治疗保留率或阿片类药物结果方面,没有显著的性别差异。因此,尽管在这一人群中存在治疗前的性别差异,但一旦开始研究治疗,女性和男性的阿片类药物使用结果相似。